M. Wolf

1.7k total citations
32 papers, 1.3k citations indexed

About

M. Wolf is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, M. Wolf has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 14 papers in Oncology and 10 papers in Genetics. Recurrent topics in M. Wolf's work include Lymphoma Diagnosis and Treatment (9 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Acute Myeloid Leukemia Research (5 papers). M. Wolf is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Acute Myeloid Leukemia Research (5 papers). M. Wolf collaborates with scholars based in Australia, Germany and United States. M. Wolf's co-authors include JP Matthews, Jeff Szer, Kathy McGrath, R. M. Fox, K. Yuen, I. A. Cooper, G. A. R. Young, Ken Bradstock, Arno Enno and D. Joshua and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Cancer.

In The Last Decade

M. Wolf

30 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Wolf Australia 15 725 287 272 238 224 32 1.3k
Peter A.W. te Boekhorst Netherlands 21 582 0.8× 263 0.9× 97 0.4× 208 0.9× 245 1.1× 50 1.1k
DJ Weisdorf United States 15 768 1.1× 390 1.4× 203 0.7× 38 0.2× 157 0.7× 19 1.4k
R. Arranz Spain 21 429 0.6× 861 3.0× 717 2.6× 51 0.2× 264 1.2× 42 1.5k
Jocelyne Flament United States 17 211 0.3× 228 0.8× 327 1.2× 269 1.1× 129 0.6× 31 955
Renée M. Y. Barge Netherlands 23 504 0.7× 343 1.2× 88 0.3× 92 0.4× 139 0.6× 44 1.5k
H. Braine United States 17 707 1.0× 323 1.1× 65 0.2× 292 1.2× 124 0.6× 25 1.1k
Nada Suvajdžić Serbia 16 649 0.9× 135 0.5× 140 0.5× 47 0.2× 215 1.0× 127 1.0k
Tapani Ruutu Finland 22 1.1k 1.6× 189 0.7× 91 0.3× 87 0.4× 361 1.6× 55 1.7k
Francesco Nobile Italy 21 846 1.2× 221 0.8× 193 0.7× 45 0.2× 516 2.3× 74 1.4k
Ignacio Lorenzo Spain 17 685 0.9× 239 0.8× 99 0.4× 42 0.2× 226 1.0× 34 946

Countries citing papers authored by M. Wolf

Since Specialization
Citations

This map shows the geographic impact of M. Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Wolf more than expected).

Fields of papers citing papers by M. Wolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Wolf. The network helps show where M. Wolf may publish in the future.

Co-authorship network of co-authors of M. Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of M. Wolf. A scholar is included among the top collaborators of M. Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Wolf. M. Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trubiano, Jason A., E. Paratz, M. Wolf, et al.. (2014). Disseminated Scedosporium prolificans infection in an ‘extensive metaboliser’: navigating the minefield of drug interactions and pharmacogenomics. Mycoses. 57(9). 572–576. 23 indexed citations
2.
Cheah, Chan Y., Kirsten Herbert, Glen Kennedy, et al.. (2014). A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma. British Journal of Cancer. 111(6). 1072–1079. 89 indexed citations
4.
5.
Prince, H. Miles, Dominic Wall, Danny Rischin, et al.. (2002). CliniMACS CD34-selected cells to support multiple cycles of high-dose therapy. Cytotherapy. 4(2). 147–155. 7 indexed citations
6.
Seymour, John F., et al.. (2002). Intrathecal Chemotherapy alone is Inadequate Central Nervous System Prophylaxis in Patients with Intermediate-grade Non-Hodgkin's Lymphoma. Leukemia & lymphoma. 43(9). 1783–1788. 51 indexed citations
7.
Dowling, Anthony, H. Miles Prince, A. Wirth, et al.. (2001). High‐dose therapy and autologous transplantation for lymphoma: The Peter MacCallum Cancer Institute experience. Internal Medicine Journal. 31(5). 279–289. 6 indexed citations
8.
Prince, H. Miles, Guy C. Toner, J.F. Seymour, et al.. (2000). Docetaxel effectively mobilizes peripheral blood CD34+ cells. Bone Marrow Transplantation. 26(5). 483–487. 13 indexed citations
9.
Lowenthal, RM, JP Matthews, Ralph Cobcroft, et al.. (1999). A Phase I/II Study of Intensive Dose Escalation of Cytarabine in Combination with Idarubicin and Etoposide in Induction and Consolidation Treatment of Adult Acute Myeloid Leukemia. Leukemia & lymphoma. 34(5-6). 501–510. 6 indexed citations
10.
Bargon, Joachim, Nurlan Dauletbaev, Benedikt Köhler, et al.. (1999). Prophylactic antibiotic therapy is associated with an increased prevalence of Aspergillus colonization in adult cystic fibrosis patients. Respiratory Medicine. 93(11). 835–838. 85 indexed citations
11.
Strickland, A. H., et al.. (1999). Fludarabine and high dose cytarabine (FLA): a well tolerated salvage regimen in acute myeloid leukaemia. Australian and New Zealand Journal of Medicine. 29(4). 556–558. 1 indexed citations
12.
13.
Matthews, JP, G. A. R. Young, Jeff Szer, et al.. (1996). A randomized study of high-dose cytarabine in induction in acute myeloid leukemia [see comments]. Blood. 87(5). 1710–1717. 337 indexed citations
14.
Wolf, M., H. Kronenberg, Anthony J. Dodds, et al.. (1996). A Safety Study of Albumex®5, a Human Albumin Solution Produced by Ion Exchange Chromatography. Vox Sanguinis. 70(4). 198–202. 2 indexed citations
15.
Cooper, I. A., M. Wolf, T. I. Robertson, et al.. (1994). Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group.. Journal of Clinical Oncology. 12(4). 769–778. 83 indexed citations
16.
Wolf, M., et al.. (1992). Levels of expression of the mdr1 gene and glutathione S-transferase genes 2 and 3 and response to chemotherapy in multiple myeloma. British Journal of Cancer. 65(3). 471–475. 53 indexed citations
17.
McGrath, Kathy, M. Wolf, JP Matthews, et al.. (1988). Clinical factors influencing the efficacy of pooled platelet transfusions. Blood. 71(2). 383–387. 163 indexed citations
18.
Juneja, Surender, et al.. (1986). The phenotype of mantle zone lymphoma studied by monoclonal antibodies. Pathology. 18(1). 131–136. 5 indexed citations
19.
Brigham, Brian A., et al.. (1981). Bone marrow necrosis diagnosed during life: clinical and laboratory features of extensive involvement.. PubMed. 11(3). 285–90. 4 indexed citations
20.
Evans, Warren H., M. Wolf, & Bruce A. Chabner. (1974). Concentration of Immature and Mature Granulocytes from Normal Human Bone Marrow. Experimental Biology and Medicine. 146(2). 526–529. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026